Baolingbao Biology Co.,Ltd. (SHE:002286)
China · Delayed Price · Currency is CNY 8.96
+0.52 (6.16%)
Nov 6, 2026, 9:25 AM CST
Baolingbao Biology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 294.65 | 273.98 | 254.95 | 242.74 | 375.95 | 585.44 |
Trading Asset Securities | - | 2.8 | - | - | - | 106.67 |
Cash & Short-Term Investments | 294.65 | 276.78 | 254.95 | 242.74 | 375.95 | 692.11 |
Cash Growth | 19.28% | 8.56% | 5.03% | -35.43% | -45.68% | 42.63% |
Accounts Receivable | 327.76 | 271.64 | 245.79 | 241.99 | 238.48 | 284.29 |
Other Receivables | 21.81 | 20.84 | 8.06 | 19.25 | 12.32 | 19 |
Receivables | 349.57 | 292.48 | 253.85 | 261.24 | 250.8 | 303.29 |
Inventory | 302.49 | 321.91 | 288.71 | 278.58 | 335.39 | 285.09 |
Prepaid Expenses | - | - | - | - | - | 0.76 |
Other Current Assets | 59.85 | 23.14 | 12.71 | 3.31 | 33.64 | 33.63 |
Total Current Assets | 1,007 | 914.3 | 810.22 | 785.87 | 995.78 | 1,315 |
Property, Plant & Equipment | 1,614 | 1,471 | 1,454 | 1,433 | 1,532 | 1,286 |
Long-Term Investments | 218.31 | 210.47 | 246.92 | 286.16 | 323.53 | 268.14 |
Other Intangible Assets | 114.99 | 114.11 | 117.5 | 121.28 | 125.07 | 129.27 |
Long-Term Deferred Tax Assets | 19.49 | 15.89 | 10.31 | 5.58 | 4.16 | 3.32 |
Long-Term Deferred Charges | 23.67 | 26.13 | 22.38 | 20.42 | 18.68 | 12.14 |
Other Long-Term Assets | 16 | 29.14 | 12.21 | 6.91 | 6.65 | 14.89 |
Total Assets | 3,013 | 2,781 | 2,674 | 2,659 | 3,006 | 3,029 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 347.24 | 227.21 | 213.11 | 237.56 | 314.16 | 634.38 |
Accrued Expenses | 24.87 | 41.71 | 39.12 | 32.84 | 38.54 | 42.22 |
Short-Term Debt | 100.07 | 102.6 | 260.19 | 209.81 | 244.17 | 369.18 |
Current Portion of Long-Term Debt | 1.31 | 9.91 | 9.51 | 42 | 85.9 | 0.5 |
Current Portion of Leases | - | 2.05 | 1.15 | 3.38 | 5.07 | 4.43 |
Current Income Taxes Payable | 19.18 | 21.64 | 5.64 | 2.66 | 4.83 | 10.87 |
Current Unearned Revenue | 24.74 | 22.67 | 33.45 | 20.3 | 42 | 29.35 |
Other Current Liabilities | 62.4 | 56.95 | 13.94 | 27.92 | 24.79 | 28.92 |
Total Current Liabilities | 579.81 | 484.74 | 576.1 | 576.47 | 759.46 | 1,120 |
Long-Term Debt | 40.03 | 10.79 | 10.79 | 48.69 | 178.39 | 30.32 |
Long-Term Leases | 0.65 | 1.19 | 1.17 | 0.25 | 3.07 | 7.45 |
Long-Term Unearned Revenue | 46.74 | 50.19 | 43.66 | 49.14 | 60.07 | 58.11 |
Long-Term Deferred Tax Liabilities | 0.76 | 0.9 | 0.71 | 0.85 | 0.8 | 0.04 |
Total Liabilities | 678.78 | 547.81 | 632.44 | 675.41 | 1,002 | 1,216 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 379.98 | 380.57 | 369.77 | 370.77 | 371.81 | 371.91 |
Additional Paid-In Capital | 900.91 | 873.24 | 812.45 | 818.51 | 830.64 | 821.56 |
Retained Earnings | 997.54 | 940.52 | 812.67 | 743.89 | 719.52 | 608.66 |
Treasury Stock | -40.56 | -42.88 | - | -7.06 | -14.4 | -18.7 |
Comprehensive Income & Other | 96.38 | 82.14 | 46.64 | 57.38 | 96.77 | 29.8 |
Total Common Equity | 2,334 | 2,234 | 2,042 | 1,983 | 2,004 | 1,813 |
Shareholders' Equity | 2,334 | 2,234 | 2,042 | 1,983 | 2,004 | 1,813 |
Total Liabilities & Equity | 3,013 | 2,781 | 2,674 | 2,659 | 3,006 | 3,029 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 142.06 | 126.54 | 282.81 | 304.13 | 516.6 | 411.88 |
Net Cash (Debt) | 152.59 | 150.24 | -27.86 | -61.39 | -140.65 | 280.23 |
Net Cash Growth | 125.79% | - | - | - | - | 17.19% |
Net Cash Per Share | 0.42 | 0.41 | -0.08 | -0.17 | -0.38 | 0.75 |
Filing Date Shares Outstanding | 354.96 | 380.57 | 369.77 | 370.77 | 371.81 | 371.91 |
Total Common Shares Outstanding | 354.96 | 380.57 | 369.77 | 370.77 | 371.81 | 371.91 |
Working Capital | 426.75 | 429.56 | 234.12 | 209.39 | 236.32 | 195.05 |
Book Value Per Share | 6.58 | 5.87 | 5.52 | 5.35 | 5.39 | 4.88 |
Tangible Book Value | 2,219 | 2,119 | 1,924 | 1,862 | 1,879 | 1,684 |
Tangible Book Value Per Share | 6.25 | 5.57 | 5.20 | 5.02 | 5.05 | 4.53 |
Buildings | - | 780.87 | 771.66 | 770.06 | - | - |
Machinery | - | 1,544 | 1,476 | 1,559 | - | - |
Construction In Progress | - | 131.36 | 115.74 | 2.57 | 40.48 | 52.85 |